Stock Market
Truist Stands Firm on Insulet Buy Despite Device Recall
By Bullbit Editorial ยท March 30, 2026
- WhatTruist maintains buy rating on Insulet
- WhyDespite device correction announcement, Truist sees potential
- SignalTruist's confidence in Insulet's long-term growth
- TargetInsulet's focus on innovation and customer satisfaction
- RiskPotential impact of device corrections on Insulet's reputation
More breaking news โ